{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-24-272464","form_type":"8-K","ticker":"TPST","cik":"0001544227","company_name":"Tempest Therapeutics, Inc.","filed_at":"2024-12-06T23:59:59+00:00","discovered_at":"2026-05-14T18:03:08.753213+00:00","generated_at":"2026-05-29T06:27:08.773872+00:00","sec_items":["1.01","3.03","5.07","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Tempest Therapeutics stockholders approve reverse stock split proposal at ratios up to 1-for-15","bullets":["Stockholders approved reverse stock split proposal at special meeting on December 3, 2024.","Ratio range: 1-for-2 to 1-for-15, inclusive, with board to set final ratio in its discretion.","Vote results: 12,723,707 for, 9,810,591 against, 415,687 abstentions.","On December 5, 2024, entered Amendment No. 2 to Rights Agreement for technical board administration changes."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-24-272464","json":"https://secwatch.observer/filing/0001193125-24-272464.json","markdown":"https://secwatch.observer/filing/0001193125-24-272464.md","text":"https://secwatch.observer/filing/0001193125-24-272464.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1544227/000119312524272464/0001193125-24-272464-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1544227/000119312524272464/d899818d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-29T06:27:08.773872+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}